Long-chain polyphosphate is a potential agent for inducing mucosal healing of the colon in ulcerative colitis.

08:00 EDT 12th September 2019 | BioPortfolio

Summary of "Long-chain polyphosphate is a potential agent for inducing mucosal healing of the colon in ulcerative colitis."

The goal of ulcerative colitis (UC) treatment has recently been shown to be "mucosal healing", as no drug directly induces mucosal healing. Probiotics possess sufficient safety, but their efficacy in the treatment of UC remains controversial because of the influence of the intestinal conditions. It is believed that the identification of bioactive molecules produced by probiotics and their application will help to solve this issue. We therefore identified a probiotic-derived long-chain polyphosphate as a molecule enhancing the intestinal barrier function. This study demonstrated that long-chain polyphosphate exhibited anti-inflammatory effects in a human macrophage and IL-10 KO transfusion mouse model. The first-in-human trial showed that 7 of the 10 enrolled acquired clinical remission, 4 of whom achieved endoscopic remission despite a history of treatment with anti-TNF-α agents. No adverse reactions were observed. Long-chain polyphosphate might be useful for the treatment of refractory UC, even in patients with failure or intolerance to anti-TNF-α therapy.


Journal Details

This article was published in the following journal.

Name: Clinical pharmacology and therapeutics
ISSN: 1532-6535


DeepDyve research library

PubMed Articles [22945 Associated PubMed Articles listed on BioPortfolio]

Wound healing potential of curcumin cross-linked chitosan/polyvinyl alcohol.

This study focusses on antibacterial properties and wound healing potential of curcumin cross-linked with chitosan-PVA membranes. In present work, the crude curcumin was extracted from the rhizome of ...

A case of nivolumab-associated colitis, which relapsed after mucosal healing and was then successfully treated with mesalazine.

Currently, the number of patients treated with immune-checkpoint inhibitor involving nivolumab is increasing. Nevertheless, it causes various immune-related adverse events (irAEs). Here, we report the...

Potential relationship between dietary long-chain saturated fatty acids and hypothalamic dysfunction in obesity.

Diet-induced hypothalamic inflammation, which leads to hypothalamic dysfunction and a loss of regulation of energy balance, is emerging as a potential driver of obesity. Excessive intake of long-chain...

Zeta Potential Changing Polyphosphate Nanoparticles: A promising approach to overcome the mucus and epithelial barrier.

The aim of the present study was to develop zeta potential changing polyphosphate nanoparticles (pp-NPs) in order to overcome the diffusion barrier of the mucus gel layer and to provide an enhanced ce...

Histologic Remission in Ulcerative Colitis: Are We There Yet?

As the field of inflammatory bowel disease moves toward treating to a "target" that includes mucosal healing, better outcome definitions are needed. One important question is whether the definition of...

Clinical Trials [9637 Associated Clinical Trials listed on BioPortfolio]

Evaluation of PUCAI Score at Assessment for Mucosal Healing During Clinical Remission in Pediatric Ulcerative Colitis

Establishing that mucosal healing (MH) has occurred after therapy is an important treatment goal, and the gold standard is endoscopic evaluation. In UC it is unclear if clinical parameters...

Study of Triheptanoin for Treatment of Long-Chain Fatty Acid Oxidation Disorder

Humans eat long-chain fat in their diet and use it for energy during exercise and during periods of fasting. Patients with long-chain fatty acid oxidation disorders cannot use dietary fat ...

A Multicenter Prospective Cohort Study on the Clinical Prognosis of Ulcerative Colitis

Mucosal healing or histological remission is an important target for the treatment of inflammatory bowel disease. In this study, patients with mucosal healing are defined as a control grou...

Biomarkers of Intestinal Mucosal Healing in Crohn's Disease (P08143)

This study will evaluate biomarkers that reflect changes in gut mucosal status during therapy with infliximab and determine whether changes in the levels of the selected biomarkers can be ...

Topical Collagen Powder for Healing of Acute Full-thickness Wounds

We have designed a pilot study to investigate the effect and potential utility of topical NuvagenTM (collagen powder) on the rate and quality of wound healing in healthy volunteers using t...

Medical and Biotech [MESH] Definitions

A flavoprotein oxidoreductase that has specificity for long-chain fatty acids. It forms a complex with ELECTRON-TRANSFERRING FLAVOPROTEINS and conveys reducing equivalents to UBIQUINONE.

Low-molecular-weight fragment of heparin, having a 4-enopyranosuronate sodium structure at the non-reducing end of the chain. It is prepared by depolymerization of the benzylic ester of porcine mucosal heparin. Therapeutically, it is used as an antithrombotic agent. (From Merck Index, 11th ed)

A water insoluble terpene fatty acid used in the treatment of gastrointestinal ulcers; it facilitates the healing and function of mucosal tissue.

A long-chain fatty acid ester of carnitine which facilitates the transfer of long-chain fatty acids from cytoplasm into mitochondria during the oxidation of fatty acids.

A mitochondrial protein consisting of four alpha-subunits and four beta-subunits. It contains enoyl-CoA hydratase, long-chain-3-hydroxyacyl-CoA dehydrogenase, and acetyl-CoA C-acyltransferase activities and plays an important role in the metabolism of long chain FATTY ACIDS.

Quick Search

DeepDyve research library

Relevant Topic

Complementary and Alternative Medicine
Alternative medicine are whole medical systems that did not fit with conventional medicine as they have completely different philosophies and ideas on the causes of disease, methods of diagnosis and approaches to treatment. Although often overlapping, co...

Searches Linking to this Article